Literature DB >> 10465590

Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes.

B Kwon1, B S Youn, B S Kwon.   

Abstract

Rapid progress in the discovery of members of the tumor necrosis factor receptor/ligand superfamilies has been made, mainly with the help of massive DNA sequencing and bioinformatic studies. Biological studies of the new members have not only indicated overlapping roles with other members but also provided insights into novel functions. In particular, multiple pairings of receptors and ligands highlight a complex control mechanism of immune responses by these superfamilies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465590     DOI: 10.1016/s0952-7915(99)80054-5

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  4 in total

1.  T cell costimulatory molecules in anti-viral immunity: Potential role in immunotherapeutic vaccines.

Authors:  Tania H Watts; Edward M Bertram; Jacob Bukczynski; Tao Wen
Journal:  Can J Infect Dis       Date:  2003-07

2.  Serum concentrations of TNF α and its soluble receptors in patients with adrenal tumors treated by surgery.

Authors:  Jan Komorowski; Jolanta Jurczynska; Tomasz Stepien; Krzysztof Kolomecki; Krzysztof Kuzdak; Henryk Stepien
Journal:  Int J Mol Sci       Date:  2010-05-26       Impact factor: 5.923

3.  A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth.

Authors:  P Rennert; P Schneider; T G Cachero; J Thompson; L Trabach; S Hertig; N Holler; F Qian; C Mullen; K Strauch; J L Browning; C Ambrose; J Tschopp
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

4.  Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.

Authors:  Stefanie Scheu; Judith Alferink; Tobias Pötzel; Winfried Barchet; Ulrich Kalinke; Klaus Pfeffer
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.